Stay connected with COPAXONE®

Sign up now


With COPAXONE®, you have a Teva’s Shared Solutions® nurse available for support. In-home, 1-on-1 injection training is also available when starting therapy.


  • New COPAXONE® patients:

    Learn tips and techniques that can help you get started with your injections and stay on track to reach your relapsing multiple sclerosis (RMS) therapy goals.

  • If you’ve recently switched to COPAXONE® or your doctor has changed your COPAXONE® dose:

    Injection methods, techniques, and side effects vary by product. A Teva-trained nurse will be able to offer tips and answer questions specific to Teva's COPAXONE®.

  • To help ensure you're rotating your injection sites properly:

    If you want to feel more confident about self-injection of COPAXONE®, Teva’s Shared Solutions® nurses can show you rotation pattern techniques that may help prevent injection site reactions.

  • To help keep your skin as healthy as possible:

    A small adjustment in the depth settings of the autoject®2 for glass syringe may help manage injection site reactions and help keep your skin healthy, especially if you’ve gained or lost enough weight to affect your clothing size.

  • To help manage your RMS therapy:

    The right tools from Teva’s Shared Solutions® may help, such as a needle clipper for more convenient syringe disposal, a free replacement autoject®2 for glass syringe after 3 years, or a travel kit.

Teva’s Shared Solutions® is here to help you create a personal injection plan.

  • Experience from more than 20 years of supporting people living with relapsing MS.

  • Effective tips and techniques to help you keep your commitment to therapy and achieve your treatment goals.

  • Education to help ensure you’re set up for success and integrate your family and Care Partners into your therapy management team.


COPAXONE® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Serious side effects may happen right after or within minutes after you inject COPAXONE® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.

You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE®. Call your doctor right away if you have chest pain while using COPAXONE®.

Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE® and choosing a different injection area each time you use COPAXONE®.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please read the Patient Information in the full Prescribing Information.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?